Physician profile
Adarsh Bhat
NPI 1861443228
$2,390.63
in general payments reported to CMS, 2019-2025
16 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $200 · 2021: $22.23 · 2022: $320 · 2023: $230 · 2024: $415 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Education: $61.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.73 |
| Education | $61.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $391.24 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $325.80 | 2019-2023 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $294.37 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $272.34 | 2019-2020 | |
| Vifor Pharma, INC. | $244.07 | 2019-2020 | |
| Glaxosmithkline, LLC. | $145.41 | 2022-2024 | Jesduvroq, Benlysta |
| Aurinia Pharma U.S., INC. | $133.99 | 2022-2023 | Lupkynis |
| Amgen INC. | $128.68 | 2023-2025 | Tavneos |
| Kyowa Kirin, INC. | $121.84 | 2024 | |
| Alexion Pharmaceuticals, INC. | $113.30 | 2024 | |
| Baxter Healthcare | $70.53 | 2019-2023 | Renal - Pd |
| Nxstage Medical, INC. | $51.40 | 2021-2025 | Nxstage System One, Liberty Select Cycler |
| Calliditas Therapeutics US INC. | $35.81 | 2025 | Tarpeyo |
| Ardelyx, INC. | $27.78 | 2024 | Ibsrela |
| Travere Therapeutics, INC. | $18.48 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $15.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adarsh Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.